Case Control Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Mar 28, 2020; 26(12): 1329-1339
Published online Mar 28, 2020. doi: 10.3748/wjg.v26.i12.1329
Figure 1
Figure 1 Flow chart of the study design. SNPs: Single-nucleotide polymorphisms; PM-DILI Polygonum multiflorum-induced liver injury; Other-DILI: Other drug-induced liver injury.
Figure 2
Figure 2 Distribution of HLA-B alleles with frequencies > 1% in the Polygonum multiflorum-induced liver injury group (n = 73).
Figure 3
Figure 3 Distribution of HLA-B alleles with frequencies > 1% in the other drug-induced liver injury group (n = 118).